Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) saw unusually-strong trading volume on Thursday . 1,722,194 shares traded hands during mid-day trading, an increase of 2,782% from the previous session’s volume of 59,756 shares.The stock last traded at $3.3750 and had previously closed at $3.3750.
Analysts Set New Price Targets
Separately, Zacks Research raised shares of Raia Drogasil to a “hold” rating in a research report on Thursday, April 9th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Raia Drogasil presently has an average rating of “Hold”.
View Our Latest Stock Report on RADLY
Raia Drogasil Price Performance
Raia Drogasil Company Profile
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Featured Articles
- Five stocks we like better than Raia Drogasil
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
